Scientists have discovered a potential new way to treat one of the most aggressive blood cancers, offering hope to thousands ...

In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.

Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

Attorney General and Minister of Legal Affairs, Anil Nandlall, on Tuesday assailed the United States for issuing its 2025 ...

A recent exchange of letters between ArcelorMittal Liberia (AML) and the Government of Liberia, represented by the National Investment Commission (NIC) and the Ministry of Mines and Energy (MME) has ...

It is an aggressive cancer that affects the blood and bone marrow and is very hard to treat. Even with improvements in care, ...

Researchers found metformin, a common diabetes drug, may protect against blood cancer AML by targeting pre-cancerous cells.

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...

Around 3,100 people are diagnosed with acute myeloid leukemia (AML) each year in the UK ... Mitochondrial metabolism sustains ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

Metformin, which is mainly used to control diabetes, could help prevent an aggressive form of blood cancer, a new study ...